Antibiotic Resistance Gets Attention Of FDA, Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
Both FDA and Congress are taking interest in combating antibiotic resistance, but FDA likely has more power to make headway in the near term, even as industry remains somewhat wary of that particular agenda item.